Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts. [electronic resource]
Producer: 20141104Description: 1159-67 p. digitalISSN:- 1532-1827
- Animals
- Antineoplastic Agents -- therapeutic use
- Asparaginase -- pharmacology
- Asparagine -- blood
- Cadherins -- analysis
- Carcinoma, Hepatocellular -- drug therapy
- Enzyme Inhibitors -- therapeutic use
- Glutamate-Ammonia Ligase -- antagonists & inhibitors
- Glutamine -- analysis
- Hep G2 Cells
- Humans
- Ki-67 Antigen -- analysis
- Liver Neoplasms -- drug therapy
- Male
- Methionine Sulfoximine -- therapeutic use
- Mice
- Mice, Nude
- Mutation
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
- beta Catenin -- analysis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.